Ingles Markets, Incorporated
Ingles Markets, Incorporated (IMKTA) Financial Performance & Income Statement Overview
Analyze Ingles Markets, Incorporated (IMKTA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Ingles Markets, Incorporated (IMKTA) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Ingles Markets, Incorporated IMKTA financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.33B | $1.29B | $1.40B | $1.39B |
| Cost of Revenue | $1.02B | $986.98M | $1.10B | $1.06B |
| Gross Profit | $310.98M | $301.13M | $299.39M | $329.76M |
| Gross Profit Ratio | $0.23 | $0.23 | $0.21 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $286.25M |
| Operating Expenses | $289.34M | $280.71M | $300.83M | $285.61M |
| Total Costs & Expenses | $1.31B | -$1.27B | $1.40B | $1.35B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $4.88M | $5.01M | $5.21M | $5.36M |
| Depreciation & Amortization | $0.00 | $30.94M | $34.09M | $29.51M |
| EBITDA | $55.08M | $57.81M | $36.32M | $77.21M |
| EBITDA Ratio | $0.04 | $0.04 | $0.03 | $0.06 |
| Operating Income | $21.64M | $20.43M | -$1.44M | $44.15M |
| Operating Income Ratio | $0.02 | $0.02 | -$0.001 | $0.03 |
| Other Income/Expenses (Net) | -$2.04M | -$1.71M | -$1.53M | -$1.81M |
| Income Before Tax | $19.60M | $21.86M | -$2.97M | $42.35M |
| Income Before Tax Ratio | $0.01 | $0.02 | -$0.002 | $0.03 |
| Income Tax Expense | $4.50M | $5.27M | -$1.50M | $10.62M |
| Net Income | $15.11M | $16.59M | -$1.47M | $31.72M |
| Net Income Ratio | $0.01 | $0.01 | -$0.001 | $0.02 |
| EPS | $0.81 | $0.89 | $5.68 | $1.71 |
| Diluted EPS | $0.80 | $0.87 | $5.68 | $1.67 |
| Weighted Avg Shares Outstanding | $18.99M | $18.99M | $18.99M | $18.59M |
| Weighted Avg Shares Outstanding (Diluted) | $18.99M | $18.99M | $18.41M | $18.99M |
Financial performance has remained strong, with revenue growing from $1.39B in Q3 2024 to $1.33B in Q2 2025. Gross profit continued to perform well, with margins at 23% in the latest quarter. Operating income reached $21.64M in Q2 2025, holding a steady 2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $55.08M. Net income dropped to $15.11M, keeping EPS at $0.81. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan